Ananda Pharma Confirms Safety of CBD Drug, as Clinical Pain Trials Approach
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDSafetyPainResearchPolicyAnxietyMental Health Why This Matters As CBD-based pharmaceuticals advance through clinical…
Cannabis loyalty isn’t built on high-potency THC – it’s built on trust
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. DosingTHCCBDSafetyIndustryResearchPolicy Why This Matters Clinicians should understand that patient cannabis use…
PSNI officer facing ‘performance procedures’ over wrongful seizure of prescribed cannabis
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicySafetyCBDTHCHempMental HealthAnxiety Why This Matters Clinicians should be aware that law enforcement may not…
Using cannabis for sleep isn’t as harmless as it seems: What to know
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SleepTHCSafetyResearchMental HealthCBDDosing Why This Matters Clinicians should counsel patients that while THC may…
Alex Trebeks Cbd Gummies: A Practical Look At The Celebrity Linked Trend [zydRGYwbdTp]
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. CBDHempSafetyResearchDosingIndustryMental Health Clinical Summary # Clinical Summary This article examines…
For decades, marijuana has been classified by the federal government as a Schedule I drug …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyIndustryTHCCBDHemp Why This Matters Rescheduling cannabis from Schedule I to Schedule III would…
What sets research-led cannabis developers apart?
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchIndustryCBDTHCSafetyPolicyNeurology Clinical Summary # Summary Research-led cannabis developers like Oxford…
Is the US Hemp Ban Punishing the Wrong People?
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. HempCBDPolicySafetyIndustryResearchAnxiety Clinical Summary # Clinical Summary The article examines how US hemp…
Massachusetts overhauls cannabis laws, raising purchase limits and tightening potency rules
✦ New CED Clinical Relevance #57 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicySafetyTHCIndustryDosingHempCBD Why This Matters Clinicians should understand these regulatory changes because…
Hemp-Derived CBD Is A ‘Promising’ Treatment For Acne Inflammation And Redness …
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchHempCBDSafetyPolicyPainAnxiety Why This Matters Clinicians managing acne patients should be aware that emerging…
